Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Non-Current Assets (2019 - 2025)

Historic Non-Current Assets for Pliant Therapeutics (PLRX) over the last 7 years, with Q3 2025 value amounting to $31.0 million.

  • Pliant Therapeutics' Non-Current Assets fell 1297.08% to $31.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $131.7 million, marking a year-over-year increase of 1950.26%. This contributed to the annual value of $34.7 million for FY2024, which is 42142.21% up from last year.
  • As of Q3 2025, Pliant Therapeutics' Non-Current Assets stood at $31.0 million, which was down 1297.08% from $32.4 million recorded in Q2 2025.
  • In the past 5 years, Pliant Therapeutics' Non-Current Assets ranged from a high of $36.2 million in Q2 2024 and a low of $4.7 million during Q1 2021
  • Moreover, its 5-year median value for Non-Current Assets was $11.2 million (2022), whereas its average is $17.8 million.
  • In the last 5 years, Pliant Therapeutics' Non-Current Assets plummeted by 4535.49% in 2023 and then soared by 48139.99% in 2024.
  • Pliant Therapeutics' Non-Current Assets (Quarter) stood at $11.8 million in 2021, then decreased by 12.5% to $10.3 million in 2022, then crashed by 35.43% to $6.7 million in 2023, then surged by 421.42% to $34.7 million in 2024, then decreased by 10.59% to $31.0 million in 2025.
  • Its Non-Current Assets stands at $31.0 million for Q3 2025, versus $32.4 million for Q2 2025 and $33.6 million for Q1 2025.